New data from Dexcom adds to the proof that wearable diabetes technology, is not costly considering the improvements it brings to quality of life and
Dexcom G6 CGM system has received the CE Mark for use during pregnancy in the EU, and will be available soon, starting with the UK
This feature shows the efforts being made to keep people with diabetes safe, supported and supplied with their vital bits of kit, from blood test
The Dexcom G6 CGM System now has CE Marking across Europe, for wear on the back of the upper arm, offering people more choice on
Pioneering diabetes researcher Professor Roman Hovorka has launched the world’s first licensed, downloadable artificial pancreas app for people with Type 1 diabetes. The CamAPS FX
Diabetes healthcare is being boosted by greater access to and understanding of what these little bits of wearable wellness can do for users. When we
The Dexcom G6 CGM sensor lasts 10 days and no confirmatory fingersticks are required (neither to dose nor for calibrations). The G6 works with a
Diabetes tech innovations and approvals are coming along thick and fast these days. In Europe, the CE Mark (Conformité Européenne) is used to indicate that
Dexcom has received CE Mark for its Dexcom G6 System for people with diabetes ages two years and up. John Lister, Dexcom’s General Manager for
The next generation of Dexcom sensor builds on the company’s existing CGM capability. It is being argued that Dexcom’s latest G6 sensors could convert CGM
